| Nov 8 |
Immunovant's Q2 Loss Wider Than Expected, Pipeline in Focus
|
| Nov 7 |
CPRX Q3 Earnings & Revenues Beat Estimates, '24 View Raised, Stock Up
|
| Nov 7 |
Pacira Q3 Earnings Top, Revenues Miss Despite Exparel Sales Growth
|
| Nov 7 |
Acadia's Q3 Earnings Beat, Nuplazid & Daybue Drive Revenue Growth
|
| Nov 6 |
NVO Misses Q3 Earnings & Revenue Estimates, Updates 2024 View
|
| Nov 6 |
Ultragenyx Q3 Loss Narrower Than Expected, Revenues Beat Estimates
|
| Nov 5 |
Editas Q3 Loss Narrower Than Expected, Revenues Decrease Y/Y
|
| Nov 5 |
Is Novartis (NVS) Stock Undervalued Right Now?
|
| Nov 5 |
Is Argenx (ARGX) Outperforming Other Medical Stocks This Year?
|
| Nov 4 |
Zoetis Q3 Earnings & Revenues Beat, '24 Outlook Raised, Stock Up
|
